IL106894A0 - Dorsal tissue affecting factor and compositions - Google Patents
Dorsal tissue affecting factor and compositionsInfo
- Publication number
- IL106894A0 IL106894A0 IL106894A IL10689493A IL106894A0 IL 106894 A0 IL106894 A0 IL 106894A0 IL 106894 A IL106894 A IL 106894A IL 10689493 A IL10689493 A IL 10689493A IL 106894 A0 IL106894 A0 IL 106894A0
- Authority
- IL
- Israel
- Prior art keywords
- compositions
- affecting factor
- tissue affecting
- dorsal tissue
- factors
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
- 230000001939 inductive effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL13465600A IL134656A0 (en) | 1992-09-03 | 2000-02-21 | Antibodies to dorsal tissue affecting factor |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US93995492A | 1992-09-03 | 1992-09-03 | |
US95041092A | 1992-09-23 | 1992-09-23 | |
US95740192A | 1992-10-06 | 1992-10-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
IL106894A0 true IL106894A0 (en) | 1994-05-30 |
Family
ID=27420696
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL134656A IL134656A (en) | 1992-09-03 | 1993-09-02 | Antibodies that bind the polypeptide nogin and hybridoma capable of producing these antibodies |
IL106894A IL106894A0 (en) | 1992-09-03 | 1993-09-02 | Dorsal tissue affecting factor and compositions |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL134656A IL134656A (en) | 1992-09-03 | 1993-09-02 | Antibodies that bind the polypeptide nogin and hybridoma capable of producing these antibodies |
Country Status (9)
Country | Link |
---|---|
US (4) | US5843775A (xx) |
EP (1) | EP0656062B1 (xx) |
JP (1) | JP3431153B2 (xx) |
AT (1) | ATE190352T1 (xx) |
AU (1) | AU676847B2 (xx) |
DE (1) | DE69328025T2 (xx) |
HK (1) | HK1008347A1 (xx) |
IL (2) | IL134656A (xx) |
WO (1) | WO1994005791A2 (xx) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994005791A2 (en) * | 1992-09-03 | 1994-03-17 | Regeneron Pharmaceuticals, Inc. | Dorsal tissue affecting factor and compositions |
US5679783A (en) * | 1994-11-22 | 1997-10-21 | The Regents Of The University Of California | DNA encoding a tissue differentiation affecting factor |
US6133232A (en) * | 1996-06-20 | 2000-10-17 | The Regents Of The University Of California | Endoderm, cardiac and neural inducing factors |
AU6267098A (en) * | 1997-02-05 | 1998-08-25 | Regents Of The University Of California, The | Morphogenic proteins |
JP4357003B2 (ja) * | 1997-02-19 | 2009-11-04 | リジェネロン ファーマシューティカルズ,インコーポレイテッド | 形態形成タンパク質 |
US6075007A (en) * | 1997-07-17 | 2000-06-13 | Regeneron Pharmaceuticals, Inc. | Modified noggin polypeptide and compositions |
AU4409899A (en) * | 1998-05-28 | 1999-12-13 | Board Of Trustees Of The University Of Arkansas, The | Noggin and antagonists of bone morphogenetic proteins to suppress pathologic bone resorption |
US6087168A (en) | 1999-01-20 | 2000-07-11 | Cedars Sinai Medical Center | Conversion of non-neuronal cells into neurons: transdifferentiation of epidermal cells |
WO2000064460A2 (en) * | 1999-04-23 | 2000-11-02 | Sulzer Orthopedics Ltd. | Composition for enhancing functional recovery of a mammal from central and/or peripheral nervous system injury of traumatic or pathological origin |
WO2001098463A1 (en) * | 2000-06-20 | 2001-12-27 | Es Cell International Pte Ltd | Method of controlling differentiation of embryonic stem (es) cells by culturing es cells in the presence of bmp-2 pathway antagonists |
WO2002054940A2 (en) * | 2001-01-12 | 2002-07-18 | University Of Medicine & Dentistry Of New Jersey | Bone morphogenetic protein-2 in the treatment and diagnosis of cancer |
WO2002087632A1 (en) * | 2001-05-02 | 2002-11-07 | Metaprobe, Inc. | High throughput screening methods using magnetic resonance imaging agents |
US20030134790A1 (en) * | 2002-01-11 | 2003-07-17 | University Of Medicine And Dentistry Of New Jersey | Bone Morphogenetic Protein-2 And Bone Morphogenetic Protein-4 In The Treatment And Diagnosis Of Cancer |
GB2385052A (en) * | 2002-02-05 | 2003-08-13 | Leuven K U Res & Dev | Treatment of spondyloarthropathies |
AU2006289667A1 (en) * | 2005-09-08 | 2007-03-15 | Apollo Life Sciences Limited | Noggin and chimeric molecules thereof |
KR101163171B1 (ko) | 2009-01-20 | 2012-07-19 | (주)케어젠 | 노긴?유래 펩타이드 및 그의 용도 |
WO2010147803A2 (en) * | 2009-06-08 | 2010-12-23 | Regents Of The University Of Michigan | Adult cerebellum-derived neural stem cells and compositions and methods for producing oligodendrocytes |
JP2016530243A (ja) * | 2013-07-18 | 2016-09-29 | アン アンド ロバート エイチ.ルリー チルドレンズ ホスピタル オブ シカゴ | 神経管欠損症を検出及び治療する組成物及び方法 |
US10179111B2 (en) * | 2014-03-07 | 2019-01-15 | University of Pittsburgh—of the Commonwealth System of Higher Education | Treating soft tissue via controlled drug release |
AT521641B1 (de) * | 2018-09-12 | 2020-07-15 | Fianostics Gmbh | Verfahren zur Diagnose von Lebererkrankungen |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4933294A (en) * | 1984-01-30 | 1990-06-12 | Icrf Patents Limited | Method of detecting truncated epidermal growth factor receptors |
JPS62502589A (ja) * | 1985-04-11 | 1987-10-08 | ザ・チヤイルドレンズ・メデイカル・センタ−・コ−ポレ−シヨン | フオン・ビルブラント因子 |
US5030576A (en) * | 1986-04-30 | 1991-07-09 | Genentech, Inc. | Receptors for efficient determination of ligands and their antagonists or agonists |
US4857637A (en) * | 1986-05-07 | 1989-08-15 | Genentech, Inc. | Methods and compositions for immunologically modulating growth hormone receptor activity |
US5219759A (en) * | 1987-04-22 | 1993-06-15 | Chiron Corporation | Recombinant DNA encoding PDGF A-chain polypeptide and expression vectors |
US5229500A (en) * | 1989-08-30 | 1993-07-20 | Regeneron Pharmaceuticals, Inc. | Brain derived neurotrophic factor |
US5177197A (en) * | 1990-02-27 | 1993-01-05 | Ludwig Institute For Cancer Research | Isolated nucleotide sequence expressing human transforming growth factor-β1-binding protein |
DE69121208T2 (de) * | 1990-09-25 | 1997-01-23 | Genentech Inc | Neuer neurotropischer faktor |
US5364769A (en) * | 1990-09-25 | 1994-11-15 | Genentech, Inc. | Nucleic acid encoding neurotrophic factor four (NT-4), vectors, host cells and methods of production |
JP4124815B2 (ja) * | 1991-10-31 | 2008-07-23 | ホワイトヘッド インスティチュート フォー バイオメディカル リサーチ | TGF−β型受容体cDNAおよびその用途 |
AU674500B2 (en) * | 1991-11-04 | 1997-01-02 | Genetics Institute, Llc | Recombinant bone morphogenetic protein heterodimers, compositions and methods of use |
WO1994005791A2 (en) * | 1992-09-03 | 1994-03-17 | Regeneron Pharmaceuticals, Inc. | Dorsal tissue affecting factor and compositions |
-
1993
- 1993-09-02 WO PCT/US1993/008326 patent/WO1994005791A2/en active IP Right Grant
- 1993-09-02 AU AU48465/93A patent/AU676847B2/en not_active Ceased
- 1993-09-02 US US08/392,935 patent/US5843775A/en not_active Expired - Lifetime
- 1993-09-02 EP EP93921339A patent/EP0656062B1/en not_active Expired - Lifetime
- 1993-09-02 JP JP50565094A patent/JP3431153B2/ja not_active Expired - Fee Related
- 1993-09-02 IL IL134656A patent/IL134656A/en not_active IP Right Cessation
- 1993-09-02 IL IL106894A patent/IL106894A0/xx not_active IP Right Cessation
- 1993-09-02 AT AT93921339T patent/ATE190352T1/de not_active IP Right Cessation
- 1993-09-02 DE DE69328025T patent/DE69328025T2/de not_active Expired - Lifetime
-
1995
- 1995-06-07 US US08/485,721 patent/US5821124A/en not_active Expired - Lifetime
-
1998
- 1998-07-15 HK HK98109178A patent/HK1008347A1/xx not_active IP Right Cessation
- 1998-10-07 US US09/167,874 patent/US6277593B1/en not_active Expired - Lifetime
-
2001
- 2001-07-02 US US09/897,322 patent/US20020102643A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP3431153B2 (ja) | 2003-07-28 |
AU676847B2 (en) | 1997-03-27 |
US6277593B1 (en) | 2001-08-21 |
EP0656062A1 (en) | 1995-06-07 |
DE69328025D1 (de) | 2000-04-13 |
US20020102643A1 (en) | 2002-08-01 |
JPH08504086A (ja) | 1996-05-07 |
US5821124A (en) | 1998-10-13 |
WO1994005791A2 (en) | 1994-03-17 |
US5843775A (en) | 1998-12-01 |
WO1994005791A3 (en) | 1994-07-07 |
AU4846593A (en) | 1994-03-29 |
DE69328025T2 (de) | 2000-11-02 |
ATE190352T1 (de) | 2000-03-15 |
IL134656A (en) | 2006-12-10 |
HK1008347A1 (en) | 1999-05-07 |
EP0656062B1 (en) | 2000-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1008347A1 (en) | Dorsal tissue affecting factor and compositions | |
IL134042A0 (en) | Modified dorsal tissue affecting factor and compositions | |
UA43348C2 (uk) | Водна фармацевтична композиція, що включає фактор росту нерва (варіанти) та ліофілізований фармацевтичний склад | |
IL80495A0 (en) | Microbial compositions,their production and their use for treating soil | |
GR3032628T3 (en) | NEW GROWTH/DIFFERENTIATION FACTOR OF THE TGF--g(b) FAMILY | |
UA39158C2 (uk) | Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі | |
GR3024597T3 (en) | 7-deazapurine modified oligonucleotides | |
AU8547691A (en) | Protein sequence-specific oligonucleotide sequences | |
DE69905170D1 (en) | Thiazolopyrimidinderivate | |
IL128231A0 (en) | Novel benzamidines | |
NZ507350A (en) | Semi-synthetic ecteinascidins and use in treatment of tumors | |
IL98134A0 (en) | Single chain t-receptors,nucleic acid sequences coding therefor and pharmaceutical compositions containing the same | |
MX9704030A (es) | 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos. | |
KR0180256B1 (en) | Bpc peptides, their preparation and use | |
EP1123414A4 (en) | ANTISENSE MODULATION OF THE EXPRESSION OF INTEGRIN ALPHA 4 | |
MY128260A (en) | Cyclopentane-and-pentene-b-amino acids | |
IL98273A0 (en) | Dna sequences,proteins having esterase activity coded by them,and use of such proteins | |
MX9806041A (es) | Proteina purificada sr-p70. | |
IL139604A0 (en) | Novel peptides | |
MX9700624A (es) | Azolidinonas de imidazopiridina. | |
PL345204A1 (en) | Compounds with growth hormone releasing properties | |
PE20399A1 (es) | Muteina ob | |
EP0584365A4 (en) | NEW AGENT FOR HAIR GROWTH AND GROWTH. | |
CA2143442A1 (en) | Dorsal tissue affecting factor and compositions | |
ES2013025A6 (es) | Un metodo para preparar 24r-escimnol. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
KB | Patent renewed | ||
KB | Patent renewed | ||
MM9K | Patent not in force due to non-payment of renewal fees |